mRNA |
Topotecan |
CTRPv2 |
pan-cancer |
AAC |
0.025 |
0.4 |
mRNA |
Bicalutamide |
GDSC1000 |
pan-cancer |
AAC |
0.025 |
0.4 |
mRNA |
OSI-930 |
CTRPv2 |
pan-cancer |
AAC |
-0.028 |
0.4 |
mRNA |
BRD-K85133207 |
CTRPv2 |
pan-cancer |
AAC |
-0.028 |
0.4 |
mRNA |
BRD-A02303741:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.027 |
0.4 |
mRNA |
Erlotinib |
GDSC1000 |
pan-cancer |
AAC |
0.036 |
0.4 |
mRNA |
selumetinib:vorinostat (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.027 |
0.4 |
mRNA |
KU-55933 |
CTRPv2 |
pan-cancer |
AAC |
-0.027 |
0.4 |
mRNA |
MK-2206 |
GDSC1000 |
pan-cancer |
AAC |
0.027 |
0.4 |
mRNA |
ABT-263 |
CTRPv2 |
pan-cancer |
AAC |
-0.027 |
0.4 |